Track topics on Twitter Track topics that are important to you
ICYMI: @BioCentury details a @newdigsMIT pilot program to address portability of performance-based annuity contracts for potentially “curative therapies.” https://bit.ly/2GuOkCo
Novartis is making what it describes us a "bolt-on acquisition" for a cool US$8.7bn, acquiring Nasdaq-listed AveXis, a clinical-stage gene therapy developer
More jobs and money are on the table for an AveXis plant in North Carolina, showing acquirer Novartis' interest in building out its gene therapy capabilities.
In addition to the $55m previously invested, Novartis will spend a further $60m in expanding AveXisâ site in North Carolina enabling the manufacture of multiple gene therapies simultaneously.
Gene therapy developer 4D Molecular Therapeutics has appointed Fred Kamal to serve as chief technical officer. Kamal joins Emeryville, CA-based 4D Molecular from Avexis, where he was senior vice presi...
Dave Lennon was chosen by Novartis to run AveXis. Says they honestly haven’t internally finalized they price yet. #PLW2019 pic.twitter.com/6cBTDoz089
AveXis is a clinical-stage gene therapy company establishing unique industry alliances to create innovative treatments in areas of unmet medical needs. The companyâs most adv...
PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare-related investments.Â Led by Paul Manning, a successful entrepreneur, PBM Capital partners w...
PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare investments.Â Led by Paul Manning, a successful entrepreneur, the PBM Capital Group partners...
We have published hundreds of AveXis, Inc. news stories on BioPortfolio along with dozens of AveXis, Inc. Clinical Trials and PubMed Articles about AveXis, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AveXis, Inc. Companies in our database. You can also find out about relevant AveXis, Inc. Drugs and Medications on this site too.
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...